Sym021 Monotherapy, in Combination With Sym022 or Sym023, and in Combination With Both Sym022 and Sym023 in Patients With Advanced Solid Tumor Malignancies or Lymphomas
PHASE1
The primary purpose of this study is to see if Sym021 is safe and tolerable...
Status
Completed
Location
South Texas Accelerated Research Therapeutics (START) Midwest
S095029 as Monotherapy and in Combination With Sym021 in Patients With Advanced Solid Tumor Malignancies Followed by an Expansion Part With Triple Combinations in Patients With Metastatic Gastric or Colorectal Cancers
PHASE1
The purpose of the study is to investigate the safety, tolerability, and pr...